In RA, Tofacitinib Has Higher Infection Rate Than TNFi

Pressbee - Medscape :

Watch the post from In RA, Tofacitinib Has Higher Infection Rate Than TNFi, Now to the details :

Patients with rheumatoid arthritis are at greater risk for infection if they're treated with tofacitinib than with a tumor necrosis factor inhibitor (TNFi), according to an industry-funded study.
MDedge News

For more, read the news from the source

In RA, Tofacitinib Has Higher Infection Rate Than TNFi

This was the summery for In RA, Tofacitinib Has Higher Infection Rate Than TNFi We hope that we have succeeded by sharing the full details of this topic.

Medscape In RA, Tofacitinib Has Higher Infection Rate Than TNFi Patients with rheumatoid arthritis are at greater risk for infection if they're treated with tofacitinib than with a tumor necrosis factor inhibitor (TNFi), according to an industry-funded study.MDedge News

Please note that the original topic has been published and is available on Medscape the editing team at PressBee have verified it and it may have been partially modified or quoted from it. You can read and follow this news or topic from its main source.

( PRESSBEE ) An independent news reader does not assume any liability for the material published in it because it does not express the opinion of the site.